Celiac disease is a genetic autoimmune condition triggered by gluten that causes the body’s immune system to attack itself, damaging the small intestine. A wide range of symptoms can occur in different individuals, including but not limited to: unexplained iron-deficiency anemia, fatigue, bone or joint pain, arthritis, seizures or migraines, abdominal bloating and pain, and […]
A member of CDF’s Medical Advisory Board, Peter Green, MD, recently studied the relationship between celiac disease (CD) and neuropathy, along with the expert knowledge of doctors Thawani, Brannagan, Lebwohl, and Ludviggson. Neuropathy is a condition that weakens nerve cells and inhibits normal nerve function. Our nerves are used for communicating with the brain and […]
Digestive Disease Week® (DDW) is the largest international gathering of physicians, researchers, and academics in the fields of gastroenterology, hepatology, endoscopy, and gastrointestinal surgery. Held on May 16-19 in Washington D.C., the meeting showcased new breakthroughs in celiac disease and gluten sensitivity research. Celiac Disease Foundation (CDF) Chief Executive Officer, Marilyn G. Geller, attended to […]
In the United States, an estimated three million Americans suffer from celiac disease. Due to lack of information about celiac disease manifestation, roughly 83% of Americans who experience symptoms go undiagnosed, and as a result, are not aware of the damage to their intestinal lining. There are also those who have the disease but show […]
On May 11, 2015, the Food and Drug Administration (FDA) will conduct a public meeting on Functional GI Disorders Patient-Focused Drug Development. Celiac Disease Foundation was requested by the FDA to provide commentary about the impact of celiac disease on patients’ daily lives, the types of treatment benefit that matter most to patients, and patients’ […]
Considering the rising number of cases of celiac disease, and its extremely detrimental effects on childhood development, leading to malabsorption and failure to thrive, it is becoming more necessary to find a means to properly diagnose young children.
Newly diagnosed patients with celiac disease were found to be at risk of metabolic syndrome and hepatic steatosis upon adopting a gluten-free diet. An in-depth nutritional assessment is recommended at diagnosis and during follow-up.
New drugs on the research horizon could spare people with celiac the pain of accidentally eating pizza or pasta. Even with the best intentions, living gluten-free is much easier said than done. It was almost impossible to tell which packaged “gluten-free” foods lived up to their claims until late last year when the U.S. Food […]
The Kansas Wheat Commission is spending $200,000 to identify everything in wheat’s DNA sequences that can trigger a reaction in people suffering from celiac disease, an autoimmune disorder in which eating even tiny amounts of gluten can damage the small intestine.
On March 30-31st, 2015, Celiac Disease Foundation Chief Executive Officer, Marilyn G. Geller, attended the FDA Public Workshop on Gastroenterology Regulatory Endpoints and the Advancement of Therapeutics (GREAT3) near Washington, D.C. This landmark conference addressed endpoints and outcome measures for trials for products intended to treat celiac disease and Irritable Bowel Disease. The second day […]